Across TCGA pan-cancer cohorts, PRR20FP RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated PRR20FP data layer.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher PRR20FP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PRR20FP expression acts as an unfavorable survival marker.
STAD are the cancer types where PRR20FP RNA most reproducibly stratifies survival.